165 related articles for article (PubMed ID: 12722031)
1. Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy.
Katafuchi R; Ikeda K; Mizumasa T; Tanaka H; Ando T; Yanase T; Masutani K; Kubo M; Fujimi S
Am J Kidney Dis; 2003 May; 41(5):972-83. PubMed ID: 12722031
[TBL] [Abstract][Full Text] [Related]
2. Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center.
Koike M; Takei T; Uchida K; Honda K; Moriyama T; Horita S; Ogawa T; Yoshida T; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2008 Aug; 12(4):250-255. PubMed ID: 18286351
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers.
Choi S; Lee D; Jeong KH; Moon JY; Lee SH; Lee TW; Ihm CG
Clin Nephrol; 2009 Nov; 72(5):353-9. PubMed ID: 19863877
[TBL] [Abstract][Full Text] [Related]
4. Pathological sub-analysis of a multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy versus steroid pulse monotherapy in patients with immunoglobulin A nephropathy.
Katafuchi R; Kawamura T; Joh K; Hashiguchi A; Hisano S; Shimizu A; Miyazaki Y; Nagata M; Matsuo S;
Clin Exp Nephrol; 2016 Apr; 20(2):244-52. PubMed ID: 26349433
[TBL] [Abstract][Full Text] [Related]
5. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.
Ballardie FW; Roberts ISD
J Am Soc Nephrol; 2002 Jan; 13(1):142-148. PubMed ID: 11752031
[TBL] [Abstract][Full Text] [Related]
6. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
7. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
[TBL] [Abstract][Full Text] [Related]
8. Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide.
Mitsuiki K; Harada A; Okura T; Higaki J
Clin Exp Nephrol; 2007 Dec; 11(4):297-303. PubMed ID: 18085391
[TBL] [Abstract][Full Text] [Related]
9. Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes.
Chen KJ; Cheng CH; Wu MJ; Chen CH; Shu KH
J Chin Med Assoc; 2003 May; 66(5):263-70. PubMed ID: 12908567
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of low-dose cyclosporine and steroid in adults with IgA nephropathy
.
Ihm HS; Lee JY; Hwang HS; Kim YG; Moon JY; Lee SH; Jeong KH; Lee TW; Ihm CG
Clin Nephrol; 2019 Sep; 92(3):131-140. PubMed ID: 31232271
[TBL] [Abstract][Full Text] [Related]
11. Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy.
Horita Y; Tadokoro M; Taura K; Ashida R; Hiu M; Taguchi T; Furusu A; Kohno S
Ren Fail; 2007; 29(4):441-6. PubMed ID: 17497466
[TBL] [Abstract][Full Text] [Related]
12. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Kitamura K
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1301-7. PubMed ID: 18508946
[TBL] [Abstract][Full Text] [Related]
13. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy.
Shoji T; Nakanishi I; Suzuki A; Hayashi T; Togawa M; Okada N; Imai E; Hori M; Tsubakihara Y
Am J Kidney Dis; 2000 Feb; 35(2):194-201. PubMed ID: 10676716
[TBL] [Abstract][Full Text] [Related]
14. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
Haramaki R; Tamaki K; Fujisawa M; Ikedo H; Haramaki N; Okuda S
Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids in IgA nephropathy: a randomised controlled trial.
Pozzi C; Bolasco PG; Fogazzi GB; Andrulli S; Altieri P; Ponticelli C; Locatelli F
Lancet; 1999 Mar; 353(9156):883-7. PubMed ID: 10093981
[TBL] [Abstract][Full Text] [Related]
17. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S
Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
Harmankaya O; Oztürk Y; Baştürk T; Obek A; Kiliçarslan I
Int Urol Nephrol; 2002; 33(1):167-71. PubMed ID: 12090325
[TBL] [Abstract][Full Text] [Related]
20. Effect of steroid pulse therapy on post-transplant immunoglobulin A nephropathy.
Matsukuma Y; Masutani K; Tsuchimoto A; Okabe Y; Nakamura M; Kitazono T; Tsuruya K
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():10-16. PubMed ID: 29968415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]